Benzocaine Topical Spray: A Local Anesthetic For Pain Management
The medicine was given to the target site with a pressurized topical spray (aerosol pharmaceutical) and a non-pressurized topical spray solution by gently pressing the spray container against the skin and initiating the spray. Formulation components consists of product concentrate (one or more pharmaceutical drugs with relevant excipient) and packaging components (valves, pump, actuator, container).Benzocaine topical spray is a widely used local anesthetic for relieving pain and discomfort from minor skin irritations, sunburns, insect bites, and mucosal abrasions. It provides rapid pain relief by blocking nerve impulses, numbing sensory nerves, and reducing pain perception. Benzocaine, an ester local anesthetic, works by reversibly inhibiting voltage-gated sodium channels to prevent action potentials along nerve fibers. The spray formulation typically includes benzocaine along with excipients like propylene glycol, glycerin, isopropyl alcohol, hydroxypropyl cellulose, ethyl cellulose, menthol, PEG 400, trisodium citrate, and peppermint oil. These ingredients aid in solubilization, stabilization, viscosity modification, and flavoring, enhancing the spray's efficacy, stability, and patient acceptance. Applied as a fine mist, benzocaine spray offers localized anesthesia with rapid onset and prolonged duration, ensuring ease of application, uniform distribution, and quick absorption through the skin or mucous membranes. This delivery system allows for precise dosing and targeted application, minimizing systemic absorption and adverse effects. Clinical studies support the safety and efficacy of benzocaine topical spray, showing favorable results in pain relief, patient satisfaction, and tolerability. However, caution is necessary to prevent overdose or misuse, as excessive use can cause systemic toxicity, allergic reactions, or other adverse effects. Overall, benzocaine topical spray is a convenient, effective, and versatile option for managing pain in medical and consumer settings.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-08-11
- DOI
- https://doi.org/10.5281/zenodo.13294538
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00